There are almost a billion women over 50 worldwide with specific personal care needs. A consumer study* identified skin sagging as one of the major signs of ageing being accentuated by menopause.
Feminage™ is a new active ingredient developed by Sederma especially dedicated to these women experiencing loss of skin elasticity and firmness caused by glycation and oxidation events related to oestrogenic decline. It also helps maintain major components of the dermal-epidermal junction (Collagen IV, collagen VII, laminin-5) and counteract inflammatory manifestations (PGE-2, IL-6 and IL-8 release reduction).
As a result, FEMINAGE™, tested at 3 % on Caucasian menopausal women in France and on Chinese menopausal women in China for 2 months, offers skin elasticity (+14 %/placebo) and firmness (+8.2 %/placebo) benefits, helping reduce jowl sagging (-11.4 %/placebo), droopy eyelids (-24.7 %/placebo), crow’s feet wrinkles (-9.5 %/placebo) and marionette lines (-14.8 %/placebo).
This eco-designed extract of Engelhardia initiates from an ethical sourcing that underwent a verification diagnostic by UEBT, a non profit association that sets good practices for how companies and their suppliers source ingredients from biodiversity. It also complies with our CSR commitments Be Actively Committed, is COSMOS approved and IECIC compliant.
Extensive clinical evaluations demonstrated the visible and significant efficacy of Feminage™ on the skin of Caucasian and Chinese women by improving elasticity and firmness while smoothing out wrinkles. These results are associated to a higher quality of the elastic tissue and a preserved fibroblast vitality against glycation and oxidation*.
* All the results of the clinical studies, as well as in vitro studies and consumer study, are available upon request through your sales representative.